Dow Jones U.S. Pharmaceuticals Index
D.J. US Pharmaceutical Top 10: Value Investment Strategy
TOP 10 Value
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Phibro Animal (L, US) Pharmaceuticals
1. Phibro Animal (L, US) Pharmaceuticals
88
5
48
44
2. Pfizer (XXL, US) Pharmaceuticals
2. Pfizer (XXL, US) Pharmaceuticals
72
5
23
15
3. Supernus Pharma (M, US) Pharmaceuticals
3. Supernus Pharma (M, US) Pharmaceuticals
67
51
27
47
4. Akorn (M, US) Pharmaceuticals
4. Akorn (M, US) Pharmaceuticals
59
12
30
30
5. Assertio Therapeutics (S, US) Pharmaceuticals
5. Assertio Therapeutics (S, US) Pharmaceuticals
59
2
1
5
6. Amphastar (M, US) Pharmaceuticals
6. Amphastar (M, US) Pharmaceuticals
51
95
59
79
7. Lannett (M, US) Pharmaceuticals
7. Lannett (M, US) Pharmaceuticals
51
22
40
29
March 13, 2020. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
D.J. US Pharmaceutical Top 10: Growth Investment Strategy
TOP 10 Growth
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Amphastar (M, US) Pharmaceuticals
1. Amphastar (M, US) Pharmaceuticals
51
95
59
79
2. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
2. Bristol-Myers Squibb (XXL, US) Pharmaceuticals
33
88
9
36
3. Zoetis (XL, US) Pharmaceuticals
3. Zoetis (XL, US) Pharmaceuticals
16
84
23
37
4. Pacira BioSciences (M, US) Pharmaceuticals
4. Pacira BioSciences (M, US) Pharmaceuticals
8
84
16
33
5. Merck & Co. (XXL, US) Pharmaceuticals
5. Merck & Co. (XXL, US) Pharmaceuticals
21
83
45
48
6. Catalent (L, US) Pharmaceuticals
6. Catalent (L, US) Pharmaceuticals
37
81
14
42
7. Supernus Pharma (M, US) Pharmaceuticals
7. Supernus Pharma (M, US) Pharmaceuticals
67
51
27
47
March 13, 2020. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
D.J. US Pharmaceutical Top 10: Safety Investment Strategy
TOP 10 Safety
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Nektar (L, US) Pharmaceuticals
1. Nektar (L, US) Pharmaceuticals
1
1
80
14
2. Amphastar (M, US) Pharmaceuticals
2. Amphastar (M, US) Pharmaceuticals
51
95
59
79
3. Phibro Animal (L, US) Pharmaceuticals
3. Phibro Animal (L, US) Pharmaceuticals
88
5
48
44
4. Johnson & Johnson (XXL, US) Pharmaceuticals
4. Johnson & Johnson (XXL, US) Pharmaceuticals
16
26
47
8
5. Merck & Co. (XXL, US) Pharmaceuticals
5. Merck & Co. (XXL, US) Pharmaceuticals
21
83
45
48
March 13, 2020. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
D.J. US Pharmaceutical Top 10: Combined Investment Strategy
TOP 10 Combined
VALUEVVV
GROWTHVV
SAFETYVV
COMBINED
1. Amphastar (M, US) Pharmaceuticals
1. Amphastar (M, US) Pharmaceuticals
51
95
59
79
2. Merck & Co. (XXL, US) Pharmaceuticals
2. Merck & Co. (XXL, US) Pharmaceuticals
21
83
45
48
3. Supernus Pharma (M, US) Pharmaceuticals
3. Supernus Pharma (M, US) Pharmaceuticals
67
51
27
47
4. Phibro Animal (L, US) Pharmaceuticals
4. Phibro Animal (L, US) Pharmaceuticals
88
5
48
44
5. Catalent (L, US) Pharmaceuticals
5. Catalent (L, US) Pharmaceuticals
37
81
14
42
March 13, 2020. Top 10s are published weekly by Top 10 schedule . (Free Stock Update )
☀ This company has a special achievement which is documented on its stock research page.
Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards .
Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value , Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from March 13, 2020.
Top 10 Stock History D.J. US Pharmaceutical
Select Top 10 Date
Jan‑2021
Aug‑2020
Mar‑2020
Oct‑2019
Apr‑2019
Nov‑2018
Jun‑2018
Oct‑2017
Apr‑2017
Jan‑2017
Jan‑2016
Jan‑2015
Jan‑2014